Senti Biosciences Publishes Research in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies.
ByAinvest
Wednesday, Apr 1, 2026 8:47 am ET1min read
SNTI--
Senti Biosciences published a study in Cell Systems demonstrating its advanced logic-gated CAR design for cell therapies. The study shows that NOT-gated chimeric antigen receptor circuits in T cells and NK cells can significantly improve efficacy, precision, and safety by selectively eliminating tumor cells while sparing healthy tissue. The research provides a systematic framework for engineering NOT-gated CAR circuits and identifies inhibitory CARs based on the LIR1 receptor as potent regulators of immune cell activity.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet